115 related articles for article (PubMed ID: 34144549)
21. Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles).
Wu VM; Huynh E; Tang S; Uskoković V
Acta Biomater; 2019 Apr; 88():422-447. PubMed ID: 30711662
[TBL] [Abstract][Full Text] [Related]
22. Cell Viability and Immunogenic Function of T Cells Loaded with Nanoparticles for Spatial Guidance in Magnetic Fields.
Pfister F; Alexiou C; Janko C
Methods Mol Biol; 2023; 2644():331-346. PubMed ID: 37142932
[TBL] [Abstract][Full Text] [Related]
23. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
[TBL] [Abstract][Full Text] [Related]
24. Effect of PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) under magnetic field on amyloid beta fibrillation process.
Mirsadeghi S; Shanehsazzadeh S; Atyabi F; Dinarvand R
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():390-397. PubMed ID: 26652388
[TBL] [Abstract][Full Text] [Related]
25. Folic acid-capped PEGylated magnetic nanoparticles enter cancer cells mostly via clathrin-dependent endocytosis.
Allard-Vannier E; Hervé-Aubert K; Kaaki K; Blondy T; Shebanova A; Shaitan KV; Ignatova AA; Saboungi ML; Feofanov AV; Chourpa I
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1578-1586. PubMed ID: 27919801
[TBL] [Abstract][Full Text] [Related]
26. Innovative superparamagnetic iron-oxide nanoparticles coated with silica and conjugated with linoleic acid: Effect on tumor cell growth and viability.
Muzio G; Miola M; Ferraris S; Maggiora M; Bertone E; Puccinelli MP; Ricci M; Borroni E; Canuto RA; Verné E; Follenzi A
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():439-447. PubMed ID: 28482548
[TBL] [Abstract][Full Text] [Related]
27. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
[TBL] [Abstract][Full Text] [Related]
29. Magnetic nanoparticle-based drug delivery for cancer therapy.
Tietze R; Zaloga J; Unterweger H; Lyer S; Friedrich RP; Janko C; Pöttler M; Dürr S; Alexiou C
Biochem Biophys Res Commun; 2015 Dec; 468(3):463-70. PubMed ID: 26271592
[TBL] [Abstract][Full Text] [Related]
30. Assessment and optimization of electroporation-assisted tumoral nanoparticle uptake in a nude mouse model of pancreatic ductal adenocarcinoma.
West DL; White SB; Zhang Z; Larson AC; Omary RA
Int J Nanomedicine; 2014; 9():4169-76. PubMed ID: 25214781
[TBL] [Abstract][Full Text] [Related]
31. Superparamagnetic Iron Oxide Nanoparticles Modified with Tween 80 Pass through the Intact Blood-Brain Barrier in Rats under Magnetic Field.
Huang Y; Zhang B; Xie S; Yang B; Xu Q; Tan J
ACS Appl Mater Interfaces; 2016 May; 8(18):11336-41. PubMed ID: 27092793
[TBL] [Abstract][Full Text] [Related]
32. Non-Temperature Induced Effects of Magnetized Iron Oxide Nanoparticles in Alternating Magnetic Field in Cancer Cells.
Hapuarachchige S; Kato Y; Ngen EJ; Smith B; Delannoy M; Artemov D
PLoS One; 2016; 11(5):e0156294. PubMed ID: 27244470
[TBL] [Abstract][Full Text] [Related]
33. Dual-responsive polymer coated superparamagnetic nanoparticle for targeted drug delivery and hyperthermia treatment.
Patra S; Roy E; Karfa P; Kumar S; Madhuri R; Sharma PK
ACS Appl Mater Interfaces; 2015 May; 7(17):9235-46. PubMed ID: 25893447
[TBL] [Abstract][Full Text] [Related]
34. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
[TBL] [Abstract][Full Text] [Related]
35. Externally Controlled Cellular Transport of Magnetic Iron Oxide Particles with Polysaccharide Surface Coatings.
Cho KH; Shin MC; Min KA
Cell Biochem Biophys; 2019 Sep; 77(3):213-225. PubMed ID: 31115834
[TBL] [Abstract][Full Text] [Related]
36. External magnetic fields affect the biological impacts of superparamagnetic iron nanoparticles.
Shanehsazzadeh S; Lahooti A; Hajipour MJ; Ghavami M; Azhdarzadeh M
Colloids Surf B Biointerfaces; 2015 Dec; 136():1107-12. PubMed ID: 26613856
[TBL] [Abstract][Full Text] [Related]
37. Cell uptake enhancement of folate targeted polymer coated magnetic nanoparticles.
Licciardi M; Scialabba C; Cavallaro G; Sangregorio C; Fantechi E; Giammona G
J Biomed Nanotechnol; 2013 Jun; 9(6):949-64. PubMed ID: 23858959
[TBL] [Abstract][Full Text] [Related]
38. Effect of Low-Field High-Frequency nsPEFs on the Biological Behaviors of Human A375 Melanoma Cells.
Zhang B; Kuang D; Tang X; Mi Y; Luo Q; Song G
IEEE Trans Biomed Eng; 2018 Sep; 65(9):2093-2100. PubMed ID: 29989943
[TBL] [Abstract][Full Text] [Related]
39. MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment.
Zou Q; Zhang CJ; Yan YZ; Min ZJ; Li CS
J Cell Biochem; 2019 Nov; 120(11):18650-18658. PubMed ID: 31338877
[TBL] [Abstract][Full Text] [Related]
40. A reliable protocol for colorimetric determination of iron oxide nanoparticle uptake by cells.
Deda DK; Cardoso RM; Uchiyama MK; Pavani C; Toma SH; Baptista MS; Araki K
Anal Bioanal Chem; 2017 Nov; 409(28):6663-6675. PubMed ID: 28918472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
